1. Single-molecule analysis reveals cooperative stimulation of Rad51 filament nucleation and growth by mediator proteins.
- Author
-
Belan O, Barroso C, Kaczmarczyk A, Anand R, Federico S, O'Reilly N, Newton MD, Maeots E, Enchev RI, Martinez-Perez E, Rueda DS, and Boulton SJ
- Subjects
- Animals, Caenorhabditis elegans metabolism, Caenorhabditis elegans Proteins metabolism, Carrier Proteins metabolism, DNA Breaks, Double-Stranded, DNA, Helminth metabolism, DNA-Binding Proteins metabolism, Gene Expression Regulation, Molecular Chaperones genetics, Molecular Chaperones metabolism, Mutation, Protein Binding, Rad51 Recombinase metabolism, Replication Protein A genetics, Replication Protein A metabolism, Signal Transduction, Single Molecule Imaging, Caenorhabditis elegans genetics, Caenorhabditis elegans Proteins genetics, Carrier Proteins genetics, DNA, Helminth genetics, DNA-Binding Proteins genetics, Rad51 Recombinase genetics, Recombinational DNA Repair
- Abstract
Homologous recombination (HR) is an essential DNA double-strand break (DSB) repair mechanism, which is frequently inactivated in cancer. During HR, RAD51 forms nucleoprotein filaments on RPA-coated, resected DNA and catalyzes strand invasion into homologous duplex DNA. How RAD51 displaces RPA and assembles into long HR-proficient filaments remains uncertain. Here, we employed single-molecule imaging to investigate the mechanism of nematode RAD-51 filament growth in the presence of BRC-2 (BRCA2) and RAD-51 paralogs, RFS-1/RIP-1. BRC-2 nucleates RAD-51 on RPA-coated DNA, whereas RFS-1/RIP-1 acts as a "chaperone" to promote 3' to 5' filament growth via highly dynamic engagement with 5' filament ends. Inhibiting ATPase or mutation in the RFS-1 Walker box leads to RFS-1/RIP-1 retention on RAD-51 filaments and hinders growth. The rfs-1 Walker box mutants display sensitivity to DNA damage and accumulate RAD-51 complexes non-functional for HR in vivo. Our work reveals the mechanism of RAD-51 nucleation and filament growth in the presence of recombination mediators., Competing Interests: Declaration of interests S.J.B. is also scientific co-founder and VP Science Strategy at Artios Pharma Ltd., Babraham Research Campus, Cambridge, UK. The other authors declare no competing interests., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF